Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07281690 · ClinicalTrials.gov registry record · Phase 3
Enhancing Skin Rejuvenation Using Laser and Exosomes
A Phase 3 study of Exosomes and Laser Therapy, sponsored by Laser Beamer Skincare.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07281690: Completed Phase 3 study of Exosomes and Laser Therapy, sponsored by Laser Beamer Skincare.
NCT07281690 is a Phase 3 study of Exosomes and Laser Therapy that has completed, run by Laser Beamer Skincare. The registered enrollment target is 20 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07281690, a Phase 3 study of Exosomes and Laser Therapy, has completed, sponsored by Laser Beamer Skincare.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Enhancing Skin Rejuvenation A Single-Blind, Randomized Control Study on the Combined Efficacy of Aerolase 1064 nm YAG Laser and Exosomes Derived from Umbilical Cord Mesenchymal Stem Cells
Primary Outcome
Primary Outcome Measure 1 Description: This outcome measures the difference between the exosome-treated and control sides using independent evaluations by three nurse practitioners. Ratings are scored on a 1-3 scale (1 = left side better, 2 = right side better, 3 = no difference). Time Frame: Day 60 Scoring Interpretation: Higher values indicate greater improvement on the exosome-treated side.
Conditions Studied
Interventions
- DEVICE 1064-nm Nd:YAG Laser Treatment
- BIOLOGICAL Topical Umbilical Cord-Derived Exosomes (UC-MSC Exosomes)
Study Locations (1)
Kansas
- LaserBeamerSkincare - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2025-07-17 |
| Phase | Phase 3 |
What the finished NCT07281690 record still lists
NCT07281690 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Exosomes appearing as the primary indexed condition, and to 2 interventions - of which 1064-nm Nd:YAG Laser Treatment is the first listed.
NCT07281690 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT07281690 about?
NCT07281690 is a clinical study titled "Enhancing Skin Rejuvenation Using Laser and Exosomes". Enhancing Skin Rejuvenation A Single-Blind, Randomized Control Study on the Combined Efficacy of Aerolase 1064 nm YAG Laser and Exosomes Derived from Umbilical Cord Mesenchymal Stem Cells
What is the current status of trial NCT07281690?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2025-03-01. Estimated completion is 2025-07-17.
What conditions does trial NCT07281690 study?
This clinical trial studies the following conditions: Exosomes, Laser Therapy.
What interventions are being tested in trial NCT07281690?
The interventions under investigation include: 1064-nm Nd:YAG Laser Treatment (DEVICE), Topical Umbilical Cord-Derived Exosomes (UC-MSC Exosomes) (BIOLOGICAL).
Who is sponsoring clinical trial NCT07281690?
This trial is sponsored by Laser Beamer Skincare, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07281690 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exosomes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07281690's enrollment target sits among peer trials
20 1956th of 2000 higher than 32 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI